Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes

[1]  R. Acharya,et al.  A Retrospective Cross-Sectional Study of Severe Breakthrough SARS-CoV-2 Infection in the General Population Requiring Hospitalization Within a Single Health System , 2022, Journal of clinical medicine research.

[2]  M. Lipsitch,et al.  SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact , 2021, Nature Reviews Immunology.

[3]  N. Stefan.  Metabolic disorders, COVID-19 and vaccine-breakthrough infections , 2021, Nature Reviews Endocrinology.

[4]  I. Diamond,et al.  Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK , 2021, Nature Medicine.

[5]  G. Paolisso,et al.  Does poor glycaemic control affect the immunogenicity of the COVID‐19 vaccination in patients with type 2 diabetes: The CAVEAT study , 2021, Diabetes, obesity and metabolism.

[6]  Colin Simpson,et al.  COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study , 2021, The Lancet Respiratory Medicine.

[7]  H. Chun,et al.  Hospitalisation among vaccine breakthrough COVID-19 infections , 2021, The Lancet Infectious Diseases.

[8]  M. Lipsitch,et al.  Covid-19 Breakthrough Infections in Vaccinated Health Care Workers , 2021, The New England journal of medicine.

[9]  E. Orenbuch-Harroch,et al.  BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel , 2021, Clinical Microbiology and Infection.

[10]  A. Nicolucci,et al.  Elevated HbA1c levels in pre‐Covid‐19 infection increases the risk of mortality: A systematic review and meta‐analysis , 2021, Diabetes/Metabolism Research and Reviews.

[11]  M. Davenport,et al.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.

[12]  R. Kishony,et al.  Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine , 2021, Nature Medicine.

[13]  A. Fiore-Gartland,et al.  Evidence for antibody as a protective correlate for COVID-19 vaccines , 2021, Vaccine.

[14]  A. Ceriello.  Diabetes, SARS-CoV-2/COVID-19 vaccines and glycemic control: Call for data , 2021, Diabetes Research and Clinical Practice.

[15]  M. Hernán,et al.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting , 2021, The New England journal of medicine.

[16]  D. Oz-Levi,et al.  Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2 , 2021, medRxiv.

[17]  M. Kabir,et al.  Comorbidities might be a risk factor for the incidence of COVID-19: Evidence from a web-based survey , 2020, Preventive Medicine Reports.

[18]  H. Peckham,et al.  Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission , 2020, Nature Communications.

[19]  G. Matarese,et al.  T Cells: Warriors of SARS-CoV-2 Infection , 2020, Trends in Immunology.

[20]  M. Zheng,et al.  Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies , 2020, Nutrition, Metabolism and Cardiovascular Diseases.

[21]  J. Banchereau,et al.  Sexual-dimorphism in human immune system aging , 2019, Nature Communications.

[22]  V. De Rosa,et al.  Type 2 Diabetes: How Much of an Autoimmune Disease? , 2019, Front. Endocrinol..

[23]  A. Cohen,et al.  Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? , 2018, Front. Immunol..

[24]  Classi fi cation and Diagnosis of Diabetes : Standards of Medical Care in Diabetes d 2019 , 2018 .

[25]  M. Emoto,et al.  Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus , 2014, Human vaccines & immunotherapeutics.

[26]  江川 裕美.  Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus : with special reference to age, body mass index, and HbA1c , 2014 .

[27]  Michael Tighe,et al.  The aged microenvironment contributes to the age‐related functional defects of CD4 T cells in mice , 2012, Aging cell.

[28]  D. Greenwood,et al.  Meta-analysis of Observational Studies , 2012 .

[29]  G. Paolisso,et al.  Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation , 2012, Diabetologia.

[30]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[31]  D. Voehringer,et al.  Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). , 2002, Blood.

[32]  A. Karchmer,et al.  Infections in patients with diabetes mellitus. , 1999, The New England journal of medicine.

[33]  No Authors.  Standards of Medical Care in Diabetes — 2021 , 2022, KIDNEYS.